Cancer continues to be the leading cause of death worldwide. Hepatocellular carcinoma (HCC), a prominent form of liver cancer, is the second leading cause of cancer-related deaths, thanks to the lack of efficient diagnostic tools and consequently late diagnosis and to the scarce of available suitable treatments. Thus, novel approaches to treat HCC are in demand. The fast-growing field of nanotechnology offers infinite possibilities to design materials in the nanoscale with unique properties due to their high surface area and small size. Nanotechnology enabled scientists to design drug delivery systems that serve multiple purposes including treatment, diagnostics and imaging. This review provides an update on the overall concept and potential of cancer nanotechnology; highlights the advances made particularly toward therapeutic nanomaterials targeting HCC. Obstacles hindering further development of nanomaterials -mediated cancer therapy will also be discussed.
Owing to their unique physicochemical properties, MXenes have emerged as promising materials for biosensing applications. This review paper comprehensively explores the recent advancements in MXene-based biosensors for health and environmental applications. This review begins with an introduction to MXenes and biosensors, outlining various types of biosensors including electrochemical, enzymatic, optical, and fluorescent-based systems. The synthesis methods and characteristics of MXenes are thoroughly discussed, highlighting the importance of these processes in tailoring MXenes for specific biosensing applications. Particular attention is given to the development of electrochemical MXene-based biosensors, which have shown remarkable sensitivity and selectivity in detecting various analytes. This review then delves into enzymatic MXene-based biosensors, exploring how the integration of MXenes with enzymes enhances sensor performance and expands the range of detectable biomarkers. Optical biosensors based on MXenes are examined, focusing on their mechanisms and applications in both healthcare and environmental monitoring. The potential of fluorescent-based MXene biosensors is also investigated, showcasing their utility in imaging and sensing applications. In addition, MXene-based potential wearable biosensors have been discussed along with the role of MXenes in volatile organic compound (VOC) detection for environmental applications. Finally, this paper concludes with a critical analysis of the current state of MXene-based biosensors and provides insights into future perspectives and challenges in this rapidly evolving field.
A variety of nanomaterials have been developed specifically for biomedical applications, such as drug delivery in cancer treatment. These materials involve both synthetic and natural nanoparticles and nanofibers of varying dimensions. The efficacy of a drug delivery system (DDS) depends on its biocompatibility, intrinsic high surface area, high interconnected porosity, and chemical functionality. Recent advances in metal-organic framework (MOF) nanostructures have led to the achievement of these desirable features. MOFs consist of metal ions and organic linkers that are assembled in different geometries and can be produced in 0, 1, 2, or 3 dimensions. The defining features of MOFs are their outstanding surface area, interconnected porosity, and variable chemical functionality, which enable an endless range of modalities for loading drugs into their hierarchical structures. MOFs, coupled with biocompatibility requisites, are now regarded as highly successful DDSs for the treatment of diverse diseases. This review aims to present the development and applications of DDSs based on chemically-functionalized MOF nanostructures in the context of cancer treatment. A concise overview of the structure, synthesis, and mode of action of MOF-DDS is provided.
Proposed antibacterial mechanisms of Cu-BTC and Cu-GA. Both MOFs release Cu 2+ ions from their framework, facilitating their attachment and internalization on the surface of both E. coli (Gram-negative) and Lactobacillus (Gram-positive) bacteria.